• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Acupoint Nerve Stimulation May Modestly Reduce Early Pain After Laparoscopic Procedures

by
November 17, 2026
in Health
Reading Time: 6 mins read
0
Acupoint Nerve Stimulation May Modestly Reduce Early Pain After Laparoscopic Procedures

Acupoint Nerve Stimulation May Modestly Reduce Early Pain After Laparoscopic Procedures

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A comprehensive systematic review and meta-analysis evaluating transcutaneous electrical acupoint stimulation has found that the noninvasive technique may provide modest reductions in acute pain intensity during the initial hours following laparoscopic surgery while simultaneously lowering the incidence of postoperative adverse effects. Led by researchers from the Acupuncture and Tuina College at Chengdu University of Traditional Chinese Medicine, the investigation synthesized data across 59 randomized controlled trials encompassing 5,166 adult patients who underwent minimally invasive abdominal operations under general anesthesia. Laparoscopic surgery has widely emerged as the standard operative modality for an extensive variety of abdominal conditions because of its reduced surgical trauma and accelerated convalescence; nevertheless, postoperative discomfort continues to represent a significant obstacle to early patient rehabilitation. Postsurgical pain after laparoscopic interventions is recognized as multifactorial, arising from surgical incisions, visceral traction, and diaphragmatic irritation caused by residual pneumoperitoneum. Insufficient pain management can delay postoperative mobilization, heighten the body’s systemic stress response, and prolong hospitalization.

Conventional post-surgical analgesic regimens depend heavily on opioid medications and nonsteroidal anti-inflammatory drugs, yet both pharmaceutical classes present well-documented clinical complications. Opioid administration is frequently complicated by adverse effects including postoperative nausea, sedation, respiratory depression, and postoperative ileus, while nonsteroidal anti-inflammatory agents carry documented risks of gastrointestinal ulceration, hemorrhage, and impaired renal function. In response to these therapeutic limitations, transcutaneous electrical acupoint stimulation has attracted clinical interest as a nonpharmacological physical modality derived from classical acupuncture that combines the principles of acupoint selection with transcutaneous electrical nerve stimulation. The intervention delivers programmed, low-frequency pulsed electrical currents of predefined intensities and frequencies through surface adhesive electrodes placed over specific anatomical acupoints. Physiologically, acupoint stimulation is reported to activate peripheral sensory afferent nerve fibers, modulate both spinal and supraspinal pathways of pain transmission, engage descending inhibitory circuits, stimulate the physiological secretion of endogenous opioid peptides, serotonin, and norepinephrine, and participate in neuro-endocrine-immune regulation without introducing pharmacological metabolites or invasive puncture hazards.

To rigorously evaluate the clinical efficacy and safety of the intervention across diverse surgical domains, the authors prospectively registered their review protocol in PROSPERO under registration code CRD420261455833 and adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 framework. The investigative team performed comprehensive, unconstrained bibliographic searches across seven biomedical databases—PubMed, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, China National Knowledge Infrastructure, the Chinese Scientific Journals Database, and the Wanfang Database—from their respective inception dates up to June 19, 2026. Two independent reviewers screened titles, abstracts, and subsequent full texts, resolving discrepancies by mutual consensus or arbitration by a third investigator. Inclusion criteria mandated randomized controlled trials conducted in adult surgical candidates aged 18 years or older undergoing general anesthesia for laparoscopic procedures, comparing transcutaneous electrical acupoint stimulation directly against blank control conditions, sham stimulation, identical baseline interventions lacking stimulation, or standard pharmacological analgesia, and reporting quantified postoperative pain scores or adverse event incidence rates.

All 59 eligible trials were conducted within hospitals across China between 2014 and 2026, representing an aggregate study population spanning ages 18 to 80 years. Across the pooled trial database, surgical specializations included 27 studies centered on gynecological procedures, 18 trials evaluating gastrointestinal surgeries, 11 investigations examining gallbladder operations, and three studies involving other or unspecified laparoscopic techniques. General anesthesia regimens incorporated varied intravenous induction and maintenance combinations across centers, such as alfentanil with etomidate, fentanyl paired with propofol, or propofol combined with remifentanil. Data extraction documented extensive heterogeneity in the physical administration parameters applied across individual trials. Stimulation frequencies varied markedly, with many protocols employing dense-and-dispersed settings such as 2/100 Hz, 2/10 Hz, 2/15 Hz, or 4/20 Hz, alongside continuous low frequencies like 2 Hz or 20 Hz, and frequencies reaching up to 1,000 Hz. Current intensities were commonly adjusted to patient-perceived maximum tolerance or fixed between 2 mA and 30 mA, with some perioperative protocols reaching up to 80 mA. The anatomical acupoints targeted most frequently included Zusanli (ST36), Neiguan (PC6), Hegu (LI4), Shenmen (HT7), and Sanyinjiao (SP6), with sessions initiated prior to anesthetic induction, sustained intraoperatively, or repeated postoperatively in recovery units.

The methodological quality of the eligible studies was assessed using a modified version of the Cochrane Risk of Bias Tool 1.0 covering sequence generation, allocation concealment, incomplete outcome data, and blinding across participants, clinical personnel, and outcome evaluators. The assessment revealed substantial methodological vulnerabilities throughout the included literature: no single trial was classified as possessing an overall low risk of bias, and every trial exhibited a high risk in at least one evaluative domain. Adequate random sequence generation was explicitly documented in only 18 of the 59 trials (30%) through techniques such as computer-generated lists, random number tables, or coin tosses, whereas the remaining trials omitted specific randomization mechanisms. Centralized or sealed envelope allocation concealment was confirmed in 23 trials (39%), while patient blinding was verified in 22 trials (37%), healthcare provider blinding was present in just seven trials (12%), and blinding of outcome assessors or analysts was documented in 16 trials (27%). Trials that failed to report blinding strategies or that used open-label experimental designs were formally graded at high risk of performance and detection bias.

When compared directly against blank control groups, very low-certainty evidence derived from 14 trials encompassing 1,222 patients indicated that electrical stimulation produced a small, statistically significant decrease in postoperative pain intensity at 6 hours following surgery, yielding a weighted mean difference of −0.60 points on a 0 to 10 visual analog or numeric rating scale (95% confidence interval: −0.83 to −0.36) and a modelled risk difference of 0.20 (95% CI: 0.16 to 0.22). At the primary observation landmark of 24 hours post-surgery, synthesized findings from 39 trials representing 3,809 patients demonstrated a weighted mean difference of −0.56 points (95% CI: −0.65 to −0.47) and a modelled risk difference of 0.23 (95% CI: 0.22 to 0.25), also characterized by very low-certainty evidence under GRADE criteria. By 48 hours following the surgical procedure, evidence aggregated from 19 trials including 1,758 patients showed that the analgesic effect narrowed to a weighted mean difference of −0.37 points (95% CI: −0.48 to −0.26) and a modelled risk difference of 0.19 (95% CI: 0.17 to 0.21). The researchers predefined the minimal clinically important difference at 0.5 points. While the point estimates at 6 and 24 hours numerically exceeded this clinical threshold, their associated 95% confidence intervals crossed the boundary, and by 48 hours both the point estimate and its entire confidence interval fell entirely below the minimal important difference.

In contrast to the continuous pain metrics, moderate-certainty evidence from 25 trials comprising 2,122 patients demonstrated that transcutaneous electrical acupoint stimulation was associated with a substantial reduction in the overall occurrence of postoperative adverse events compared with blank controls, yielding a relative risk of 0.56 (95% CI: 0.49 to 0.65). Documented adverse outcomes across the trials primarily comprised postoperative nausea, vomiting, and dizziness. Statistical consistency was notable for this safety endpoint, presenting an I-squared value of 0.0%, which justified grading the evidence at moderate certainty despite unblinded study designs. In secondary comparisons evaluating the technique directly against standard pharmaceutical analgesia, low-certainty evidence from two trials totaling 198 patients indicated negligible difference in pain intensity at 24 hours, displaying a weighted mean difference of 0.07 points (95% CI: −0.04 to 0.17) and a modelled risk difference of −0.09 (95% CI: −0.21 to 0.03). Simultaneously, low-certainty evidence pooled across five trials involving 400 patients showed that participants receiving electrical acupoint stimulation experienced significantly fewer adverse complications than those treated with standard pharmacological analgesia (relative risk: 0.43, 95% CI: 0.30 to 0.62; I-squared: 17.1%).

To explore the substantial statistical heterogeneity observed across the primary and secondary pain analyses—where I-squared statistics reached 92.65% at 6 hours, 85.09% at 24 hours, and 72.06% at 48 hours—the authors executed prespecified exploratory subgroup analyses stratified by the category of laparoscopic surgery performed. For the primary outcome at 24 hours, the treatment effect size proved consistent across gynecologic surgery (20 trials), gastrointestinal surgery (13 trials), and gallbladder surgery (5 trials), showing no statistically significant subgroup interaction (P = 0.60). Similarly, interaction tests revealed no significant differences across surgical types at 6 hours (P = 0.93) or at 48 hours (P = 0.41). However, high residual heterogeneity persisted within each individual surgical subgroup, with I-squared values ranging between 80.5% and 89.1% in the 24-hour analyses. The researchers concluded that operative classification does not account for the observed variance, noting that residual differences likely stemmed from diverse electrical pulse frequencies, stimulation durations, device types, varying acupoint combinations, differing baseline anesthetic agents, and individual patient pain thresholds.

In discussing their results, the authors highlighted that the time-limited analgesic benefit—diminishing markedly by 48 hours—coincides with both the transient biological duration of peripheral electrical stimulation and the natural gradual resolution of peritoneal distension and diaphragmatic irritation caused by surgical gas insufflation. Because the observed reduction in numeric pain scores is modest and confidence intervals straddle the minimal important difference, transcutaneous electrical acupoint stimulation cannot be considered an equivalent substitute for established pharmacological regimens. Rather, the modality is best positioned as an adjunctive, non-pharmacological component within Enhanced Recovery After Surgery (ERAS) pathways, where its demonstrated ability to lower adverse event rates may offer particular value to patients vulnerable to opioid-induced respiratory depression, nausea, or delayed intestinal transit. The authors also underscored important limitations: the evidence is constrained by universal geographic concentration within China, where clinical familiarity and equipment access are widespread, and by pervasive risks of bias regarding incomplete allocation concealment and participant blinding. Consequently, the investigators emphasized that confirming the generalizability and therapeutic role of this noninvasive modality will require rigorously designed, international multicenter clinical trials utilizing standardized electrical stimulation parameters.

Subject of Research: Transcutaneous electrical acupoint stimulation for postoperative pain management and adverse event reduction in laparoscopic surgery

Article Title: Efficacy and safety of transcutaneous electrical acupoint stimulation for postoperative pain following laparoscopic surgery: a systematic review and meta-analysis

Article References: Chen, J.-J., Liao, X.-Q., Hu, Z.-Y., & Zhou, H.-Y. (2026). Efficacy and safety of transcutaneous electrical acupoint stimulation for postoperative pain following laparoscopic surgery: a systematic review and meta-analysis. Frontiers in Medicine, 13, Article 1947806. https://doi.org/10.3389/fmed.2026.1947806

Image Credits: AI Generated

DOI: 10.3389/fmed.2026.1947806

Keywords: transcutaneous electrical acupoint stimulation, laparoscopic surgery, postoperative pain, systematic review, meta-analysis, analgesia, randomized controlled trials, adverse events, GRADE assessment, visual analog scale, numeric rating scale, acupuncture points, perioperative care, opioid sparing, surgical recovery, clinical trials

News Source: Ophelia Keating. (November 17, 2026). Acupoint Nerve Stimulation May Modestly Reduce Early Pain After Laparoscopic Procedures. Scienmag.

Tags: acupuncture pointsadverse eventsanalgesiaClinical TrialsGRADE assessmentLaparoscopic SurgeryMeta-analysisnumeric rating scaleopioid sparingperioperative carePostoperative Painrandomized controlled trialssurgical recoverysystematic reviewtranscutaneous electrical acupoint stimulationvisual analog scale
Share12Tweet7Share2ShareShareShare1

Related Posts

E-Bike Crashes Involve Higher Polytrauma Rates and Steep Age-Related Mortality Increases

E-Bike Crashes Involve Higher Polytrauma Rates and Steep Age-Related Mortality Increases

November 19, 2026
Dedication and Absorption Drive Employee Performance in Yemeni Hospitals

Dedication and Absorption Drive Employee Performance in Yemeni Hospitals

November 19, 2026

Singapore Cervical Cancer Mortality Declines Significantly Despite Global Rise Projections

November 19, 2026

Perceived School Support Linked to Digital Civic Responsibility in Chinese Vocational Students

November 19, 2026

POPULAR NEWS

  • First-Principles Calculations Reveal High Thermoelectric Efficiency and Half-Metallicity in Co2VPb Alloy

    First-Principles Calculations Reveal High Thermoelectric Efficiency and Half-Metallicity in Co2VPb Alloy

    29 shares
    Share 12 Tweet 7
  • Mobile Bird Hosts Enable Regional Gene Flow in Crater Lake Parasites

    29 shares
    Share 12 Tweet 7
  • Ultrasound Shows Low Diagnostic Accuracy for Sexing Immature Agile Frogs

    29 shares
    Share 12 Tweet 7
  • Lithuanian Forest Foragers Link Solitary Mushroom Gathering to Cross-Border Trade

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Plant Pathogenic Fungus Outperforms Classic White-Rot Strains in Dye Decolorization

Biogenic Zinc Oxide Nanoparticles Protect Baculovirus Bioinsecticides From Ultraviolet Inactivation

Dual-Function Polymer Dots Enable Fluorescent Cell Imaging and Light-Activated Therapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.